The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia
Por:
Ahlgren, L, Pilheden, M, Sturesson, H, Song, GC, Walsh, MP, Yang, MJ, Maillard, M, Zhao, HB, Cheng, ZS, Singh, V, Castor, A, Pronk, CJ, Marquart, HV, Lausen, B, Schneider, P, Barbany, G, Tamm, KP, Abrahamsson, J, Lohi, O, Fogelstrand, L, Menendez, P, Pieters, R, Zhang, JH, Lindkvist-Petersson, K, Yang, JJ, Gruber, TA, Stam, RW, Ma, J and Hagström-Andersson, AK
Publicada:
8 oct 2025
Ahead of Print:
8 oct 2025
Resumen:
To study the mechanisms of relapse in KMT2A-rearranged (KMT2A-r) acute lymphoblastic (ALL) and acute myeloid leukemia (AML), we performed whole-genome and exome sequencing of infants and children with relapsed ALL/AML (n = 36), and longitudinal deep-sequencing of 257 samples in 30 patients. Somatic alterations in drug-response genes, most commonly in TP53 and IKZF1 (64%), were highly enriched in early relapse ALL (79%, 9-36 months after diagnosis), but rare in very early relapse ALL (<9 months, 9%). A marked chemotherapy-exposure signature was detected for mutations in early relapse ALL but not in very early ALL or AML relapse, in line with different mechanisms of relapse. Longitudinal analyses could track residual leukemia cells, clonal drug responses, and the upcoming relapse. These results highlight that KMT2A-r ALL and AML evade therapy differently and provide insights into the mechanisms of relapse in this highly lethal form of pediatric acute leukemia.
Filiaciones:
Ahlgren, L:
Lund Univ, Dept Lab Med, Div Clin Genet, Lund, Sweden
Pilheden, M:
Lund Univ, Dept Lab Med, Div Clin Genet, Lund, Sweden
Sturesson, H:
Lund Univ, Dept Lab Med, Div Clin Genet, Lund, Sweden
Song, GC:
St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA
Walsh, MP:
St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA
Yang, MJ:
Lund Univ, Dept Lab Med, Div Clin Genet, Lund, Sweden
Maillard, M:
St Jude Childrens Res Hosp, Dept Pharm & Pharmaceut Sci, Memphis, TN USA
Zhao, HB:
St Jude Childrens Res Hosp, Dept Pharm & Pharmaceut Sci, Memphis, TN USA
Cheng, ZS:
St Jude Childrens Res Hosp, Ctr Appl Bioinformat, Memphis, TN USA
Singh, V:
Lund Univ, Dept Lab Med, Div Clin Genet, Lund, Sweden
Castor, A:
Skane Univ Hosp, Childhood Canc Ctr, Lund, Sweden
Pronk, CJ:
Skane Univ Hosp, Childhood Canc Ctr, Lund, Sweden
Marquart, HV:
Natl Univ Hosp, Dept Clin Immunol, Rigshosp, Copenhagen, Denmark
Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
Lausen, B:
Univ Copenhagen, Dept Paediat & Adolescent Med, Rigshosp, Copenhagen, Denmark
Schneider, P:
Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
Univ Barcelona, Sch Med, Barcelona, Spain
Barbany, G:
Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
Tamm, KP:
Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden
Abrahamsson, J:
Univ Gothenburg, Inst Clin Sci, Sahlgrenska Acad, Dept Pediat, Gothenburg, Sweden
Lohi, O:
Tampere Univ, Fac Med & Hlth Technol, Tampere Ctr Child Adolescent & Maternal Hlth Res, Tampere, Finland
Tampere Univ Hosp, Tays Canc Ctr, Tampere, Finland
Fogelstrand, L:
Sahlgrens Univ Hosp, Reg Vastra Gotaland, Dept Clin Chem, Gothenburg, Sweden
Univ Gothenburg, Inst Biomed, Dept Lab Med, Gothenburg, Sweden
:
Univ Barcelona, Josep Carreras Leukemia Res Inst, Barcelona, Spain
Inst Catalana Recerca i Estudis Avancats ICREA, Barcelona, Spain
Univ Barcelona, Sch Med, Dept Biomed, Barcelona, Spain
ISCIII, Spanish Canc Network CIBERONC, Madrid, Spain
Pediat Canc Ctr Barcelona St Joan Deu Hosp PCCB SJ, Barcelona, Spain
Pieters, R:
Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
Zhang, JH:
St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN USA
Lindkvist-Petersson, K:
Lund Univ, Dept Expt Med Sci Med Struct Biol, Lund, Sweden
Yang, JJ:
St Jude Childrens Res Hosp, Dept Pharm & Pharmaceut Sci, Memphis, TN USA
Gruber, TA:
Stanford Univ, Sch Med, Dept Pediat, Stanford, CA USA
Stam, RW:
Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
Ma, J:
St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA
Hagström-Andersson, AK:
Lund Univ, Dept Lab Med, Div Clin Genet, Lund, Sweden
Lund Univ, Ctr Translat Genom, Lund, Sweden
Green Submitted, Green Accepted, gold
|